2003
DOI: 10.1046/j.1540-8167.2003.90405.x
|View full text |Cite
|
Sign up to set email alerts
|

Overview of the Management of Atrial Fibrillation:

Abstract: Management of Atrial Fibrillation. There are three fundamental approaches to the management of atrial fibrillation (AF): rate control, rhythm control, and anticoagulation. Selecting a course of treatment requires a thorough knowledge of these therapeutic alternatives. This article explores treatment options, including the relative benefits of rate control versus rhythm control, which are complicated by the lack of highly effective and safe antiarrhythmic drugs. Anticoagulation is also an important issue in AF … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0
3

Year Published

2005
2005
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 52 publications
0
6
0
3
Order By: Relevance
“…Present antiarrhythmic drug approaches for sinus rhythm maintenance suffer from limited efficacy and a significant risk of adverse effects, particularly proarrhythmia. 1 One potential approach to improving drug therapy is the identification of novel ionic targets. 2 We have previously identified a time-dependent inwardly rectifying…”
mentioning
confidence: 99%
“…Present antiarrhythmic drug approaches for sinus rhythm maintenance suffer from limited efficacy and a significant risk of adverse effects, particularly proarrhythmia. 1 One potential approach to improving drug therapy is the identification of novel ionic targets. 2 We have previously identified a time-dependent inwardly rectifying…”
mentioning
confidence: 99%
“…On the contrary all patients over 65, or patients with risk factors regardless of their age should receive anticoagulation with drugs such as warfarin or acenocumarol. Of note, the antithrombotic treatment in patients with paroxysmal or asymptomatic AF is often omitted [20][21][22]. Obviously, this is an error since current evidence strongly suggests that such patients should receive anticoagulation at the same level of intensity as patients with other forms of AF [4,11,13].…”
Section: Reduction Of Thromboembolic Riskmentioning
confidence: 99%
“…Obviously, this is an error since current evidence strongly suggests that such patients should receive anticoagulation at the same level of intensity as patients with other forms of AF [4,11,13]. Asymptomatic or short paroxysmal episodes of AF predispose to stroke while the first presenting symptom of AF is stroke in a sizable percentage of patients [21,22]. Another common mistake is the premature discontinuation of antithrombotic treatment in patients with thromboembolic risk factors after successful cardioversion.…”
Section: Reduction Of Thromboembolic Riskmentioning
confidence: 99%
See 1 more Smart Citation
“…1, адаптировано по [10,11]). Тем не менее вопрос о влиянии нейромодуляции на аритмогенез до конца не изучен [12][13][14].…”
unclassified